For the year, the company reported profit of $887.9 million, or $10.67 per share. Revenue was reported as $3.9 billion. Idexx expects full-year earnings to be $11.74 to $12.24 per share, with revenue ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results.
IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...
Learn more about whether IDEXX Laboratories, Inc. or Zimmer Biomet Holdings, Inc. is a better investment based on AAII's A+ ...
IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...
sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Shares of IDEXX Laboratories Inc. IDXX slipped 1.71% to $460.56 Thursday, on what proved to be an all-around mixed trading ...
Equities research analysts at William Blair decreased their Q1 2025 earnings per share estimates for shares of IDEXX ...
Antonio Henriques, 26, of Portland allegedly grabbed the teen by the shoulders, tried to kiss them, and offered them alcohol before following them home.
IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.
WESTBROOK, Maine - IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported fourth quarter earnings and revenue that exceeded analyst expectations, sending shares up 0.70% in early trading on Monday.
In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other stocks Jim Cramer recently looked at. On Mad Money, Jim Cramer recently delved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results